FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/12/2026
Back to search
Official data from USPTO
GENEX G
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
04/03/2026
Trademark type
Word
Nice classes
5, 10
Filing date
01/27/2023
Registration date
11/05/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/05/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
AYALA, LOURDES
Law office
L60
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Biocomposites Limited
Representatives
JOHN A. YIRGA Watts Law LLC
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medical preparations for the treatmentreconstructionaugmentation and repair of human tissuenone being bone cement or acrylic resin for surgical and orthopaedic purposes; bone paste for medical use in bone and joint surgery; bone paste incorporating pharmaceutical agentsfor surgical and medical purposes; syringes sold filled with bone paste for surgical and medical purposes
Class 10
Medical and surgical devicesapparatus and instruments all for use in bone and joint surgeryregenerationreconstruction and augmentation; bone implants composed of artificial materialsbone repair compound for use in bone and joint surgerybone regenerationbone reconstruction and bone augmentation; bone implants composed of artificial materials; synthetic bone void fillers; surgical and medical implants made of artificial materials; surgical and medical implants comprised of implantable artificial materials for surgical repairregenerationreconstruction and augmentation of human tissue; syringes for medical purposes; medical applicatorsspatulas for medical use
Publications
History of USPTO decisions and trademark events.
30 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/24/2026
FIMP
FINAL DISPOSITION PROCESSED
01/24/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/26/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/25/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/05/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
11/05/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/20/2024
PUBO
PUBLISHED FOR OPPOSITION
08/20/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/31/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/12/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/11/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/11/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/11/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/22/2024
GNRT
NON-FINAL ACTION E-MAILED
04/22/2024
CNRT
NON-FINAL ACTION WRITTEN
04/22/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/23/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/23/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/23/2024
RFNP
REFUSAL PROCESSED BY IB
11/28/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/04/2023
RFRR
REFUSAL PROCESSED BY MPU
11/04/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/03/2023
CNRT
NON-FINAL ACTION WRITTEN
11/02/2023
DOCK
ASSIGNED TO EXAMINER
10/26/2023
MAFR
APPLICATION FILING RECEIPT MAILED
07/29/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/25/2023
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
07/24/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/06/2023
Continuous trademark protection
Get notified about every new filing that threatens GENEX G or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.